Jersey City, New Jersey July 23, 2008: The DG3 Group, a leading provider of global graphic communications solutions, announced today the launch of PI Plus™ v2.0, the premier Web-based management application for the production and distribution of prescribing information, commonly called Package Inserts (PIs), and Patient Package Inserts (PPIs).
PI Plus is being marketed to the pharmaceutical industry by PharmAid Solutions™, DG3’s newly formed division announced earlier this month. PharmAid Solutions is comprised of a dedicated group of communications specialists and offers multiple services tailored to special needs of the pharmaceutical client.
PI Plus v2.0 is a secure Web-based application customized for each pharmaceutical client’s business requirements. The system is the most comprehensive application available to manage PI procurement and was designed to eliminate much of the administrative burden of PI print production. PI Plus enables clients to manage the entire lifecycle of PI documents including; online proofreading, establishing purchase order limits, ordering, version and inventory control, destruction of obsolete inventory, distribution to multiple destinations, full reconciliation of purchase orders and inventory levels, and online invoicing.
“This product is DG3’s first technology offering to the pharmaceutical industry, a core growth market for DG3. We received so much positive feedback after the launch of PI Plus v1.0 that we determined we should invest to enhance the system to handle a much wider range of tasks”, commented Dr. Michael Cunningham, DG3’s CEO.
To learn more about PI Plus v2.0, contact DG3 and PharmAid Solutions at 201-793-5342 or visit www.piplus.com.
About The DG3 Group of Companies
DG3 is a leading provider of worldwide print and communications solutions operating in strategic geographic markets worldwide including Jersey City, London, Hong Kong, Tokyo, Sydney, and Manila. DG3 provides comprehensive graphic communication solutions to corporate, financial services, pharmaceutical and academic institutions worldwide. For more information, please visit www.dg3.com
Executive Vice President, Corporate Development